Background: The burden of Kaposi sarcoma (KS) is increasing fast among HIV-infected populations, but the disease remains desperately underexplored in Cameroon, where the burden of HIV is high. Methods: This is a retrospective cross-sectional study carried out over a period of 16 years (January 2001 to December 2016) at the HIV day care unit of the Central Hospital of Yaoundé, Cameroon. The diagnosis was based on clinical aspects and histological confirmation, and we used a preconstructed questionnaire for data collection through patients’ electronic and physical files. Results: Among 14,220 files reviewed, 316 cases of KS were identified, yielding a cumulative incidence of 2.2%. In the end, 266 patients (55% male) were included in this stud...
International audienceOBJECTIVE:Kaposi sarcoma is still observed among people living with HIV (PLHIV...
Background/objective: Kaposi sarcoma (KS) is now the most frequently reported malignant skin tumour ...
Objectives: To determine the incidence and risk factors associated with Kaposi's sarcoma (KS) occurr...
Background: Since the advent of the HIV/AIDS pandemic, Kaposi\'s sarcoma (KS) is now seen in places ...
Kaposi's sarcoma has been strongly linked with HIV/AIDS epidemic in many countries. Data on Kaposi's...
Abstract: Background: Kaposi’s sarcoma (KS) is a rare neoplasm with indolent progression. Since 198...
Background. Despite the increased incidence of Kaposi sarcoma (KS) resulting from the Human Immunode...
BACKGROUND: Endemic Kaposi's sarcoma (KS) is a clinically and epidemiologically distinct human immun...
Background/objective: To study the pathology of Kaposi\'s sarcoma and review relevant literature on ...
International audienceBackground: Although antiretroviral therapy (ART) has reduced the risk of Kapo...
International audienceOBJECTIVE:Kaposi sarcoma is still observed among people living with HIV (PLHIV...
Background/objective: Kaposi sarcoma (KS) is now the most frequently reported malignant skin tumour ...
Objectives: To determine the incidence and risk factors associated with Kaposi's sarcoma (KS) occurr...
Background: Since the advent of the HIV/AIDS pandemic, Kaposi\'s sarcoma (KS) is now seen in places ...
Kaposi's sarcoma has been strongly linked with HIV/AIDS epidemic in many countries. Data on Kaposi's...
Abstract: Background: Kaposi’s sarcoma (KS) is a rare neoplasm with indolent progression. Since 198...
Background. Despite the increased incidence of Kaposi sarcoma (KS) resulting from the Human Immunode...
BACKGROUND: Endemic Kaposi's sarcoma (KS) is a clinically and epidemiologically distinct human immun...
Background/objective: To study the pathology of Kaposi\'s sarcoma and review relevant literature on ...
International audienceBackground: Although antiretroviral therapy (ART) has reduced the risk of Kapo...
International audienceOBJECTIVE:Kaposi sarcoma is still observed among people living with HIV (PLHIV...
Background/objective: Kaposi sarcoma (KS) is now the most frequently reported malignant skin tumour ...
Objectives: To determine the incidence and risk factors associated with Kaposi's sarcoma (KS) occurr...